Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Canna-Cures Research and Development Center, Inc. was a Florida-based biotechnology company focused on the research, development, and distribution of medical cannabis and hemp-derived products. Founded by Richard Pertile, the company specialized in the extraction of high-cannabidiol (CBD) and low-tetrahydrocannabinol (THC) oils using proprietary technology. Its business model encompassed the entire value chain, from genetic seed selection and cultivation to pharmaceutical-grade processing and retail distribution. In 2016, the company was acquired by Acacia Diversified Holdings, although the acquisition was later rescinded. Canna-Cures aimed to advance the therapeutic use of cannabinoids for various health conditions, with a particular focus on developing pediatric-targeted formulations and dietary supplements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Canna-Cures Research and Development Center.